5 Questions Pharma Companies Are Asking About AI

Artificial Intelligence Medication Adherence Patient Engagement Patient Outcomes Patient Support Programs Predictive Analytics

Navigating pharmaceutical digital innovation and AI

In a world with unprecedented connectivity and computational power, it’s no surprise that AI is one of the most significant technological advancements propelling the healthcare industry into uncharted territories. As pharmaceutical companies strive to stay at the forefront of scientific discovery, though, especially regarding medication adherence and patient engagement, they find themselves grappling with a host of questions about using and integrating AI into their operations.

The intersection of pharmaceuticals and AI holds immense promise, yet it also raises a series of intriguing and complex queries. In this article, we’ll explore into five major questions pharmaceutical companies often ask as they navigate the use of innovative AI.

1. How do we define success when using AI?

Successful implementation starts with identifying a specific use case, removing mere experimentation and establishing a clear intention for AI integration. This strategic approach ensures a focused alignment with company objectives and links the integration to measurable returns on investment (ROI) and tangible business results.

To succeed, pharmaceutical companies must meticulously define their objectives, securing stakeholder buy-in through a detailed plan encompassing timelines, milestones, and dependencies. This process provides the necessary structure for robust financial planning and lays the groundwork for actionable steps, creating a tactical strategy in the dynamic intersection of pharmaceuticals and AI.

For example, when using AI for patient omnichannel marketing and patient support programs, pharma organizations can measure their success via improving the number of patients starting therapy, increasing on-time refills, a higher email open rate, or optimized phone call completion by nurses.

2. How can we best embrace change?

The prevailing economics of AI-driven drug research and development (R&D) present a compelling case for change, challenging the industry to overcome the staggering 96 percent failure rate that has long characterized drug R&D. The traditional approach, involving the screening of vast numbers of molecules and enduring high failure rates in human trials, is being eclipsed by innovative methodologies.

The industry can best embrace change by defining clear objectives, identifying practical use cases, and securing stakeholder buy-in. Additionally, developing comprehensive plans while investing in talent and training are essential. By adopting these strategic measures, the pharmaceutical industry positions itself to harness the full potential of AI, revolutionizing drug discovery, development, and healthcare outcomes.

RELATED: Find out how pharma companies use AI to improve medication adherence  across the drug lifecycle.

3. How is AI currently being used within pharma?

AI is revolutionizing the pharmaceutical industry by expediting drug discovery, optimizing clinical trials, and advancing personalized medicine. In drug development, AI analyzes vast datasets to design novel compounds, identifies and validates potential targets, and aids in repurposing existing drugs. It enhances clinical trial efficiency by predicting patient responses and optimizing recruitment. AI also plays a crucial role in personalized medicine, tailoring treatments based on individual characteristics.

Additionally, it contributes to supply chain optimization, improves diagnostics through image analysis, utilizes natural language processing for literature mining, and employs targeting at the individual level to drive patient engagement and medication behaviors. The dynamic integration of AI continues to reshape pharmaceutical practices, fostering innovation and efficiency across diverse domains.

4. What are the current predictions for AI and its use cases?

The current predictions for AI and its use cases suggest a continued and expanding influence across diverse industries. AI is expected to significantly influence drug discovery, improve diagnostic accuracy, and shape personalized patient experiences in healthcare. Moreover, AI-driven virtual assistants and chatbots will likely assist with patient engagement and provide support. Truly effective use of AI however will come in the form of AI-powered personalization, allowing for Patient Support Programs (PSPs) to engage with patients on an individual level that supports therapy initiation and adherence throughout their experience. 

5. What are the cost savings my organization can achieve with AI?

Implementing AI in a healthcare organization offers substantial cost-saving opportunities. Automating repetitive workflows, administrative tasks, predictive analytics for resource management, and optimized clinical trials or PSPs can enhance operational efficiency and reduce labor costs. 

Another area where AI can help save costs is optimizing patient medication initiation and adherence. With AllazoHealth’s Impact Calculator, discover how AI gives you a more complete picture of personalized healthcare experiences. Calculate the impact of AI on your brand and program performance through true personalization now. This multifaceted application of AI, including personalized healthcare experiences, holds promise for significant efficiency gains and financial benefits for manufacturers.

How AllazoHealth empowers patient-centric initiatives

In conclusion, integrating AI into the pharmaceutical landscape marks a paradigm shift that demands careful navigation and strategic foresight. The five critical questions explored in this blog underscore the complexity and transformative potential at the intersection of pharmaceuticals and AI.

For patient marketers and PSPs seeking a better understanding of AI, AllazoHealth is here to help. Our AI-driven personalization technology enhances patient engagement, optimizes medication initiation, and improves medication adherence. AllazoHealth makes the path to an impactful AI strategy both attainable and transformative, steering initiation and adherence initiatives toward unparalleled success and improved patient outcomes. Interested in leveraging AI and predictive analytics for your PSPs and patient marketing strategies? Request a demo to explore how AllazoHealth can be a valuable asset for your needs.

eBook: Why Pharma Marketers Need Artificial Intelligence Now